Lisa C. Taylor
Founder and Principal

Lisa is a senior communications professional with two decades of experience developing and executing communications strategies for global public companies with a focus in biotech, pharmaceuticals and medtech.

Through LCT Communications, Lisa provides strategic communications support for biotech, pharma and medtech companies as well as other healthcare organizations.

From her first internship at a community hospital to leading media relations for a rare disease company, Lisa’s passion for the industry has only grown. She has seen firsthand how people’s lives can be transformed by new developments in medicine and medical technology.

Lisa’s aim in launching LCT Communications is to support this life-changing work through impactful communications programs that resonate with their intended audiences, remain authentic to a company’s brand and deliver on their goals and objectives.

Lisa’s professional experience includes the following roles:

• Senior Director, Corporate Communications at Alexion Pharmaceuticals (acquired by AstraZeneca)

• Senior Director, Communications for Global and US Rare Diseases at Sanofi Genzyme

• Director, Corporate Communications; Media Relations Manager; Internal Communications Manager at Covidien (acquired by Medtronic)

• Communications Manager at Tyco International (Divested healthcare business as Covidien)

• Communications Specialist, Communications Leadership Development Program (CLDP) at GE